Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5956 AL 5970

Neuroimaging signature of neuropsychiatric disorders

Worbe Y.

Curr Opin Neurol. 2015 Aug;28(4):358-64. doi: 10.1097/WCO.0000000000000220.

Can clock drawing differentiate Alzheimer's disease from other dementias?

Tan LP, Herrmann N, Mainland BJ, Shulman K.

Int Psychogeriatr. 2015 Oct;27(10):1649-60. doi: 10.1017/S1041610215000939. Epub 2015 Jul 3.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease

Cummings J, Zhong K.

Clin Pharmacol Ther. 2015 Nov;98(5):483-5. doi: 10.1002/cpt.190. Epub 2015 Aug 31.

The Concept of Subconsciousness in Alzheimer's and Parkinson's Diseases

Agid Y.

J Parkinsons Dis. 2015;5(3):643-5. doi: 10.3233/JPD-150573.

Semantic profiles in mild cognitive impairment associated with Alzheimer's and Parkinson's diseases

Guidi M, Paciaroni L, Paolini S, Scarpino O, Burn DJ.

Funct Neurol. 2015 Apr-Jun;30(2):113-8. doi: 10.11138/fneur/2015.30.2.113.

Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment

Korczyn AD.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S159-61. doi: 10.1016/j.parkreldis.2015.09.053. Epub 2015 Oct 19.

Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease

Goldman JG, Aggarwal NT, Schroeder CD.

Neurodegener Dis Manag. 2015 Oct;5(5):425-43. doi: 10.2217/nmt.15.34. Epub 2015 Oct 30.

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease

Soursou G, Alexiou A, Ashraf GM, Siyal AA, Mushtaq G, Kamal MA.

Curr Drug Metab. 2015;16(8):705-12. doi: 10.2174/138920021608151107125049.

Deep Assessment: A Novel Framework for Improving the Care of People with Very Advanced Alzheimer's Disease

Lyons G, Arthur-Kelly M, Eidels A, Mavratzakis A.

Biomed Res Int. 2015;2015:749451. doi: 10.1155/2015/749451. Epub 2015 Nov 24.

Biparietal variant of Alzheimer's disease: a rare presentation of a common disease

Marques IB, Tábuas-Pereira M, Milheiro M, Santana I.

BMJ Case Rep. 2015 Jan 5;2015:bcr2014207011. doi: 10.1136/bcr-2014-207011.

Neuropsychological assessment and differential diagnosis in young-onset dementias

Sitek EJ, Barczak A, Harciarek M.

Psychiatr Clin North Am. 2015 Jun;38(2):265-79. doi: 10.1016/j.psc.2015.01.003. Epub 2015 Mar 7.

Genetic testing and counseling in the diagnosis and management of young-onset dementias

Goldman JS.

Psychiatr Clin North Am. 2015 Jun;38(2):295-308. doi: 10.1016/j.psc.2015.01.008. Epub 2015 Mar 18.

The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics

Bicchi I, Emiliani C, Vescovi A, Martino S.

Neurodegener Dis. 2015;15(6):313-21. doi: 10.1159/000435917. Epub 2015 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias